Global Nutrigenomics Market Size, Share, Trends & Growth Analysis Report 2026-2034

Description

The Nutrigenomics Market size is expected to reach USD 2.87 Billion in 2034 from USD 0.65 Billion (2025) growing at a CAGR of 17.97% during 2026-2034.

The nutrigenomics market is expanding as personalized nutrition and precision health gain global attention. Nutrigenomics integrates genetic profiling with dietary recommendations to optimize health, prevent disease, and enhance metabolic outcomes. Rising consumer interest in wellness, preventive healthcare, and data-driven nutrition is driving adoption across healthcare, fitness, and supplement industries.

Technological innovation is fueling market growth. Genomic sequencing, AI-driven dietary analysis, and biomarker integration enable precise, personalized nutrition plans. Digital platforms and wearable devices allow real-time tracking, health monitoring, and feedback, enhancing compliance and efficacy. Functional foods and supplements are increasingly formulated based on individual genetic profiles, bridging science with personalized wellness.

Future growth is expected from rising awareness, healthcare digitization, and regulatory recognition of personalized nutrition. North America and Europe lead adoption due to advanced healthcare infrastructure, while Asia-Pacific is witnessing rapid growth driven by urbanization and lifestyle health trends. Strategic collaborations between biotech firms, nutraceutical companies, and digital health platforms are expanding accessible nutrigenomics solutions. Nutrigenomics is poised to redefine personalized wellness, combining genomics, nutrition, and AI-driven insights.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Application

Obesity
Cardiovascular Diseases
Cancer Research
Others

By Product

Reagents & Kits
Services

By Technique

Saliva
Buccal Swab
Blood

By End Use

Hospitals & Clinics
Others

COMPANIES PROFILED

Nutrigenomix, The Gene Box, Metagenics, Xcode Life, GX Sciences LLC Fagron, Cura Integrative Medicine, dnalife, Genova Diagnostics GDX, Holistic Health International LLC
We can customise the report as per your requirements.

Product Code: VMR11218331

Chapter 1. PREFACE

1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

2.1. Market Snapshot
2.2. Segmental Outlook
2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

3.1. Market Lineage Outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Value Chain Analysis
3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
3.6. Porter's Five Forces Analysis
3.7. PESTLE Analysis

Chapter 4. GLOBAL NUTRIGENOMICS MARKET: BY APPLICATION 2022-2034 (USD MN)

4.1. Market Analysis, Insights and Forecast Application
4.2. Obesity Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.3. Cardiovascular Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.4. Cancer Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL NUTRIGENOMICS MARKET: BY PRODUCT 2022-2034 (USD MN)

5.1. Market Analysis, Insights and Forecast Product
5.2. Reagents & Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.3. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL NUTRIGENOMICS MARKET: BY TECHNIQUE 2022-2034 (USD MN)

6.1. Market Analysis, Insights and Forecast Technique
6.2. Saliva Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.3. Buccal Swab Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.4. Blood Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL NUTRIGENOMICS MARKET: BY END USE 2022-2034 (USD MN)

7.1. Market Analysis, Insights and Forecast End Use
7.2. Hospitals & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.3. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL NUTRIGENOMICS MARKET: BY REGION 2022-2034(USD MN)

8.1. Regional Outlook
8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.2.1 By Application
- 8.2.2 By Product
- 8.2.3 By Technique
- 8.2.4 By End Use
- 8.2.5 United States
- 8.2.6 Canada
- 8.2.7 Mexico
8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.3.1 By Application
- 8.3.2 By Product
- 8.3.3 By Technique
- 8.3.4 By End Use
- 8.3.5 United Kingdom
- 8.3.6 France
- 8.3.7 Germany
- 8.3.8 Italy
- 8.3.9 Russia
- 8.3.10 Rest Of Europe
8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.4.1 By Application
- 8.4.2 By Product
- 8.4.3 By Technique
- 8.4.4 By End Use
- 8.4.5 India
- 8.4.6 Japan
- 8.4.7 South Korea
- 8.4.8 Australia
- 8.4.9 South East Asia
- 8.4.10 Rest Of Asia Pacific
8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.5.1 By Application
- 8.5.2 By Product
- 8.5.3 By Technique
- 8.5.4 By End Use
- 8.5.5 Brazil
- 8.5.6 Argentina
- 8.5.7 Peru
- 8.5.8 Chile
- 8.5.9 South East Asia
- 8.5.10 Rest of Latin America
8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.6.1 By Application
- 8.6.2 By Product
- 8.6.3 By Technique
- 8.6.4 By End Use
- 8.6.5 Saudi Arabia
- 8.6.6 UAE
- 8.6.7 Israel
- 8.6.8 South Africa
- 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

9.1. Recent Developments
9.2. Company Categorization
9.3. Supply Chain & Channel Partners (based on availability)
9.4. Market Share & Positioning Analysis (based on availability)
9.5. Vendor Landscape (based on availability)
9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL NUTRIGENOMICS INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Company Profiles
- 10.2.1 Nutrigenomix
- 10.2.2 The Gene Box
- 10.2.3 Metagenics
- 10.2.4 Xcode Life
- 10.2.5 GX Sciences LLC (Fagron)
- 10.2.6 Cura Integrative Medicine
- 10.2.7 Dnalife
- 10.2.8 Genova Diagnostics (GDX)
- 10.2.9 Holistic Health International LLC